Skip to main content
Explore URMC

menu

A study evaluating KTE-X19, a cell therapy infusion for leukemia

Research Question:
What is the safety and effectiveness of KTE-X19, a cell therapy (infusion) for patients with acute lymphoblastic leukemia (ALL)?

Basic Study Information

Purpose:
The primary objectives of this study are to determine the safety and effectiveness of KTE-X19, a cell therapy (infusion) for adult participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL).

Location: University of Rochester Medical Center
Study Reference #: ILEU15075

Lead Researcher (Principal Investigator)

Lead Researcher: Kristen O'Dwyer

Study Contact Information

Study Coordinator: Haley Misch
Phone: (585) 275-9485
Email: Haley_Misch@URMC.Rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search